Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Thorax

• Publication date

  1992-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thx.47.11.932PMID 1465751PMCID PMC464099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical experience with pamidronate in the treatment of Paget's disease of bone.

  1991cited by this paper
• A Two-Site Immunoradiometric Assay for Pth(1–84) Using N and C Terminal Specific Monoclonal Antibodies

  1991cited by this paper
• A comparison of low versus high dose pamidronate in cancer-associated hypercalcaemia.

  1991cited by this paper
• Glucocorticoid-induced osteoporosis: pathogenesis and management.

  1990cited by this paper
• Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

  1990cited by this paper
• Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis

  1990cited by this paper
• Side-effects of pamidronate.

  1989cited by this paper
• Performance evaluation of a dual-energy X-ray bone densitometer

  1989cited by this paper
• Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

  1988cited by this paper
• Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis.

  1988cited by this paper
• ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS

  1986cited by this paper
• Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

  1985cited by this paper
• Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.

  1984cited by this paper
• Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome.

  1984cited by this paper
• Circulating vitamin D metabolites and hypercalcaemia of malignancy.

  1984cited by this paper
• Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy.

  1983cited by this paper
• Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

  1983cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• Biochemical markers of bone turnover in Paget's disease.

  1981cited by this paper
• Effects of Short Term Glucocorticoid Administration on Intestinal Calcium Absorption and Circulating Vitamin D Metabolite Concentrations in Man

  1981cited by this paper
• Bone disease after jejuno-ileal bypass for obesity.

  1978cited by this paper
• Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.

  1978cited by this paper
• Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.

  1977cited by this paper
• Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects.

  1975cited by this paper
• Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis.

  1972cited by this paper
• DIPHOSPHONATES AND PAGET'S DISEASE OF BONE

  1971cited by this paper
• Diphosphonates and Page's disease of bone.

  1971cited by this paper
• Diphosphonates Inhibit Hydroxyapatite Dissolution in vitro and Bone Resorption in Tissue Culture and in vivo

  1969cited by this paper

• Glucocorticoid-induced osteoporosis and Cushing’s syndrome

  2021cites this paper
• Glucocorticoid‐Induced Osteoporosis

  2018cites this paper
• PreventionandTreatmentof Glucocorticoid-induced Osteoporosis

  2017cites this paper
• Bisphosphonates for steroid-induced osteoporosis.

  2016cites this paper
• Glucocorticoid-induced Osteoporosis.

  2016cites this paper
• Treatment of Sarcoidosis.

  2015cites this paper
• Bisfosfonatos: Aplicaciones Actuales en Osteoporosis y Cáncer

  2014cites this paper
• Bone safety of low‐dose glucocorticoids in rheumatic diseases

  2014cites this paper
• Chapter 49 – Glucocorticoid-Induced Osteoporosis

  2013cites this paper
• MUSCULOSKELETAL ASPECTS OF SARCOIDOSIS

  2009cites this paper
• CHAPTER 44 – Glucocorticoid-Induced Osteoporosis

  2008cites this paper
• Treatment of Sarcoidosis

  2008cites this paper
• Evidence-based therapy for cutaneous sarcoidosis.

  2007cites this paper
• Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

  2007cites this paper
• Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis

  2007cites this paper
• Prevention of osteoporosis in glucocorticoid-treated neurology patients.

  2006cites this paper
• Chapter 18 – Bisphosphonates in the Prevention and Treatment of Postmenopausal Osteoporosis

  2006cites this paper
• Bone Loss in Patients before and after Lung Transplantation

  2005cites this paper
• Comparison of Intravenous Pamidronate to Standard Therapy for Osteoporosis: Use in Patients Unable to Take Oral Bisphosphonates

  2005cites this paper
• Osteoporosis en la Enfermedad Pulmonar Obstructiva Crónica

  2004cites this paper
• Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy.

  2004cites this paper
• Bisphosphonate treatment of osteoporosis.

  2003cites this paper
• Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions.

  2003cites this paper
• Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.

  2003cites this paper
• Glucocorticoid-induced osteoporosis.

  2003cites this paper
• Osteoporosis in chronic obstructive pulmonary disease

  2003cites this paper
• The Effect of Intravenous Pamidronate on Bone Mineral Density, Bone Histomorphometry, and Parameters of Bone Turnover in Adults with Type IA Osteogenesis Imperfecta

  2003cites this paper
• A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis

  2002cites this paper
• COPD and osteoporosis.

  2002cites this paper
• Prevention and Treatment of Osteoporosis in the Cystic Fibrosis

  2001cites this paper
• Primary Prevention of Glucocorticoid‐Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1‐Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium Alone

  2001cites this paper
• Treatment of osteoporosis with bisphosphonates.

  2001cites this paper
• Prevention and treatment of osteoporosis in the cystic fibrosis population.

  2001cites this paper
• Osteoporosis due to cancer treatment: pathogenesis and management.

  2000cites this paper
• Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis

  2000cites this paper
• Glucocorticoid-induced osteoporosis.

  2000cites this paper
• Pamidronate therapy as prevention of bone loss following renal transplantation.

  2000cites this paper
• Trends in Inflammatory Bowel Disease Therapy 1999

  2000cites this paper
• Metabolic bone disease associated with total parenteral nutrition.

  2000cites this paper
• New perspectives in the prevention and treatment of glucocorticoid-induced osteoporosis

  2000cites this paper
• Bisphosphonates for steroid induced osteoporosis.

  2000cites this paper
• Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.

  2000cites this paper
• Management of low bone mass in patients with inflammatory bowel disease

  2000cites this paper
• Diagnosis and Treatment of Osteoporosis Associated with Immunosuppressive Therapy

  1999cites this paper
• Intravenous pamidronate attenuates bone density loss after acute spinal cord injury.

  1999cites this paper
• Bones and Crohn's: problems and solutions.

  1999cites this paper
• A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis.

  1999cites this paper
• Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.

  1998cites this paper
• Treatment of osteoporosis with bisphosphonates.

  1998cites this paper
• Prevention and treatment of glucocorticoid‐induced osteoporosis

  1998cites this paper
• Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.

  1998cites this paper
• Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.

  1998cites this paper
• Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.

  1998cites this paper
• Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study

  1998cites this paper
• Osteoporosis in adults with cystic fibrosis

  1998cites this paper
• [Treatment of post menopausal osteoporosis with intravenous pamidronate in patients with esophagogastric pathology].

  1998cites this paper
• Pathogenesis and Treatment of Glucocorticoid-Induced Osteoporosis

  1998cites this paper
• Glucocorticoid-induced osteoporosis: assessment and treatment.

  1998cites this paper
• Corticosteroid-Induced Osteoporosis: Can it Be Prevented and Treated?

  1998cites this paper
• Secondary osteoporosis.

  1997cites this paper
• Glucocorticoid osteoporosis--mechanisms and management.

  1997cites this paper
• Steroid-induced osteoporosis--a cause for concern?

  1997cites this paper
• Normal bone, osteoporosis and the rheumatologist.

  1997cites this paper
• Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid Patients

  1997cites this paper
• CYCLICAL ETIDRONATE INCREASES LUMBAR SPINE BONE DENSITY IN PATIENTS ON LONG‐TERM GLUCOCORTICOSTEROID THERAPY

  1997cites this paper
• ENDOCRINE-METABOLIC EFFECTS OF ASTHMA TREATMENT: The Impact of Glucocorticoid Therapy in the Elderly

  1997cites this paper
• Glucocorticoid-induced osteoporosis: prevention and treatment.

  1997cites this paper
• Glucocorticoid-induced osteoporosis: novel approaches.

  1997cites this paper
• Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intermittent Intravenous Pamidronate: A Randomized Trial

  1997cites this paper
• Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment.

  1996cites this paper
• Intravenous administration of alendronate counteracts theIn vivo effects of glucocorticoids on bone remodeling

  1996cites this paper
• Cyclical pamidronate infusions in postmenopausal osteoporosis.

  1996cites this paper
• Bisphosphonates

  1996cites this paper
• Osteoporosis of Crohn’s Disease: A Critical Review

  1996cites this paper
• Low-dose prednisone and increased risk of development of bone metastases.

  1996cites this paper
• Comparative Clinical Pharmacology and Therapeutic Use of Bisphosphonates in Metabolic Bone Diseases

  1996cites this paper
• Corticosteroid-Induced Bone Loss

  1996cites this paper
• Preventing and Treating Glucocorticoid Osteoporosis

  1996cites this paper
• Bisphosphonates and the Treatment of Bone Disease in the Elderly

  1996cites this paper
• Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

  1995cites this paper
• Review article: osteoporosis, corticosteroids and inflammatory bowel disease.

  1995cites this paper
• Management of corticosteroid‐induced osteoporosis

  1995cites this paper
• osteoporosis, corticosteroids and inflammatory bowel disease

  1995cites this paper
• Bile acid and immunosuppressive therapy in primary biliary cirrhosis

  1995cites this paper
• Osteoporosis in Glucocorticoid-Dependent Asthmatic Patients

  1995cites this paper
• Corticosteroid-induced osteoporosis.

  1994cites this paper
• Treatment of osteoporosis with bisphosphonates.

  1994cites this paper
• Glucocorticoid-induced osteoporosis.

  1994cites this paper
• Association of severe haemophilia A with osteoporosis: a densitometric and biochemical study.

  1994cites this paper
• Prevention and treatment of glucocorticoid-induced osteoporosis.

  1993cites this paper
• Clinical pharmacology of corticosteroids in bronchial asthma.

  1993cites this paper
• An Evaluation of Bone Density and Turnover in Premenopausal Women with Type 1 Diabetes Mellitus

  1993cites this paper